We have recently demonstrated that selective participation and overexpression of Fra-2 in presence of c-Jun is associated with aggressive tumor phenotype of HPV−ve TSCCs and its selective silencing by Fra-2-siRNA suppressed tumor metastasis [6]. This evidence concerns the gene JUN and neoplasm.